Okay. Yeah, so I think there are a few different stages of a non-QM loan cycle, when we -- from when we launch and originates that Ellington Financial, buys it during the warehouse period, and then we securitize it and put the retained tranches on our balance sheet and each kind of stage has a different ROE profile. I mean I would say, overall, we look for a low mid-teens on the whole cycle leverage factoring in, but there, as Larry mentioned, lots of variables go into that analysis. So, the first is, where is the loan originated and what kind of levered return, can we make while we hold it on repo lines? To that end it kind of looking back to an earlier question on the call, the new entrants in the market have certainly attracted better financing and as the market matures and there are more consistent securitizations in the market and more I think certainty on the exit and the outcome, I think warehouse lenders are more comfortable taking on a risk and in pricing a tighter. So, spreads on repo facilities have definitely got better over the last one to two years. So, that's helped the ROE during the warehouse process. The timing and the economics of securitization are obviously dependent on where the market is at that moment. But I think, as Larry mentioned in his remarks, we were pleased with the performance of our third deal in June. And that's kind of going according to plan. And then the retained trenches, you know, you put them on the balance sheet and probably the mid-teens conservatively levered. So, the life cycle again, we get to the low to mid-teens, but the other kind of big input is how many securitization we can do for a year. So, we've done one per year over the last couple of years, but at this point, we did one in June, we're back at $140 million as, as we mentioned and the last deal was in the $250 million range. We did 50 in July of new origination. So, if we can get to the point, where we're doing a couple of deals a year, I think, we will be closer to the mid-teens ROE as opposed to the low-teens.